Gyre Therapeutics, Inc. GYRE Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s net debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s net debt?
- Gyre Therapeutics, Inc. (GYRE) reported net debt of -$36.68M in Q1 2026.
- How has Gyre Therapeutics, Inc.'s net debt changed year-over-year?
- Gyre Therapeutics, Inc.'s net debt decreased by 172.5% year-over-year, from -$13.46M to -$36.68M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s net debt has grown at a 4.7% compound annual growth rate (CAGR), from -$28.72M to -$36.13M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.